Summary: Garofalo Health Care S.p.A.

  • Overall, the company has poor fundamentals for a medium to long-term investment strategy.

Highlights: Garofalo Health Care S.p.A.

  • Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
  • Analysts covering this company mostly recommend stock overweighting or purchase.

Weaknesses: Garofalo Health Care S.p.A.

  • As estimated by analysts, this group is among those businesses with the lowest growth prospects.
  • The company is in debt and has limited leeway for investment
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings Chart: Garofalo Health Care S.p.A.

Source: Surperformance

Fundamentals Valuation Revisions of Fundamental Estimates Capi.($)
- 526M
16.03B
13.74B
11.97B
11.34B
10B
8.05B
7.03B
5.89B
4.82B
Average 8.94B
Weighted average by Cap.
See all sector ratings
Investor
-
Trader
ESG MSCI
-

Financials

Sales growth
EPS Growth
Profitability
-
Net margin
Financial Health
-

Valuation

P/E ratio
EV/REVENUE
EV/EBITDA
PBR
Yield
-

Revisions

1 year Revenue revision
4 months Revenue revision
1 months Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analysts' recommendations
4m Revision of opinion
Potential Price Target
4m Target Price Revision
12m Target Price Revision

Business Predictability

Earnings quality
Analyst Coverag
Divergence of analysts' recommendations
Divergence of Target Price
-
Divergence of analysts' opinions
-

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. GHC Stock
  4. Ratings Garofalo Health Care S.p.A.